Leucine-restricted diet for gastric cancer patients
Part of Cancer, Digestive system clinical trials.
This trial tests if a diet low in leucine (an amino acid) can help treat gastric cancer before surgery. It aims to see if it's safe and effective for patients who are preparing for tumor removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with stomach cancer and need endoscopic marking or tumor mapping before surgery.
- You are between 18 and 70 years old.
- You can eat food or take liquid feed through a tube in your nose or stomach.
- You have signed a consent form and agree to join the study.
- Your cancer has not spread to other parts of the body (scans show no distant spread), and surgery is possible.
- You do not have another active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special diet low in leucine (an amino acid) combined with chemotherapy and immunotherapy drugs can help treat locally advanced gastric cancer before surgery. The goal is to see if this combination is safe and more effective than standard treatment alone.
This trial studies whether a program of exercise and liquid nutrition given through a tube (enteral nutrition) after surgery for stomach cancer can help people live longer. It may help you recover better and improve survival.
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This study looks at proteins in your blood to find different types of stomach cancer. The goal is to match you with the best treatment before surgery, which may improve outcomes.
This study tests whether a special diet low in leucine (an amino acid) combined with chemotherapy and immunotherapy can safely treat advanced stomach cancer that has spread. Researchers want to see if this dietary approach helps the treatment work better and reduces side effects.
This trial tests a new combination of low-dose radiation, an immunotherapy drug (tirelizumab), and chemotherapy (SOX) given before surgery for locally advanced gastric or gastroesophageal junction cancer. The goal is to see if this approach can shrink tumors more effectively.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.